Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatment.

PURPOSE: With increasing patient self-empowerment and participation in decision making, we hypothesized that patients with adult-type diffuse gliomas, CNS WHO grade 4 who change sites of treatment differ from patients being entirely treated in one neuro-oncological center. METHODS: Prospectively collected data from all diffuse glioma grade 4 patients who underwent treatment in our neuro-oncological center between 2012 and 2018 were retrospectively examined for differences between patients having initially been diagnosed and/or treated elsewhere (External Group) and patients having entirely been treated in our neuro-oncological center (Internal Group). Additionally, a matched-pair analysis was performed to adjust for possible confounders. RESULTS: A total of 616 patients was analyzed. Patients from the External Group (n = 78) were significantly younger, more frequently suffered from IDH-mutant astrocytoma grade 4, had a greater extent of tumor resection, more frequently underwent adjuvant therapy and experienced longer overall survival (all p < 0.001). However, after matching these patients to patients of the Internal Group considering IDH mutations, extent of resection, adjuvant therapy, age and gender, no difference in patients' overall survival was observed anymore. CONCLUSION: The present study demonstrates that mobile diffuse glioma grade 4 patients stand out from a comprehensive diffuse glioma grade 4 patient cohort due to their favorable prognostic characteristics. However, changing treatment sites did not result in survival benefit over similar patients being entirely taken care of within one neuro-oncological institution. These results underline the importance of treatment and molecular markers in glioma disease for patients' self-empowerment, including changing treatment sites according to patients' needs and wishes.

A novel reconstruction tool (syngo DynaCT Head Clear) in the post-processing of DynaCT images to reduce artefacts and improve image quality.

BACKGROUND: Latest generations of flat detector (FD) neuroangiography systems are able to obtain CT-like images of the brain parenchyma. Owing to the geometry of the C-arm system, cone beam artifacts are common and reduce image quality, especially at the periphery of the field of view. An advanced reconstruction algorithm (syngo DynaCT Head Clear) tackles these artifacts by using a modified interpolation-based 3D correction algorithm to improve image quality. MATERIALS AND METHODS: Eleven volumetric datasets from FD-CT scans were reconstructed with the standard algorithm as well as with the advanced algorithm. In a two-step data analysis process, two reviewers compared dedicated regions of the skull and brain in both reconstruction modes using a 5-point scale (1, much better; 5, much worse; advanced vs standard algorithm). Both reviewers were blinded to the reconstruction mode. In a second step, two additional observers independently evaluated image quality of the 3D data (non-comparative evaluation) in dedicated regions also using a 5-point scale (1, not diagnostically evaluable; 5, good quality, perfectly usable for diagnosis) for both reconstruction algorithms. RESULTS: Both in the comparative evaluation of dedicated brain regions and in the independent analysis of the FD-CT datasets the observers rated a better image quality if the advanced algorithm was used. The improvement in image quality was statistically significant at both the supraganglionic (p=0.018) and the infratentorial (p=0.002) levels. CONCLUSIONS: The advanced reconstruction algorithm reduces typical artifacts in FD-CT images and improves image quality at the periphery of the field of view.